Dynamk Capital
Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies. We partner with life science visionaries whose market-defining ideas are shaping the future of how therapeutics are being developed, increasing access for patients, and reducing costs.
📥 Buy Full VC Dataset
Offices: New York (United States)
Investment Stages: Seed, Series A, Series B
Markets: Life Science Industrials, tools, technologies, services for the discovery, development and production of life-saving therapies
Founded Year: 2017
Investor Type: Venture Capital
Portfolio Companies: Virica Biotech, Lucid Scientific, Alpenglow Biosciences, CellFE Biotech, Curibio, RoosterBio, Vectron Biosolutions, Vernal Biosciences, CellFE Biotech, Envisagenics, RESIPHER, Xcell Bioscience
Website: https://www.dynamk.vc
Team Page: https://www.dynamk.vc/team
Portfolio Link: https://www.dynamk.vc/dynam-capital-portfolio-companies
LinkedIn: https://www.linkedin.com/company/dynamkvc
Twitter: https://twitter.com/DynamkVC
Crunchbase: https://www.crunchbase.com/organization/dynamk-capital
Pitchbook: https://pitchbook.com/profiles/investor/156046-69
Comments
No comments yet. Be the first to comment!